45
Participants
Start Date
May 31, 2001
Primary Completion Date
March 31, 2005
Study Completion Date
March 31, 2005
Aldurazyme
Placebo for 26 weeks then 0.58 mg/kg Aldurazyme every week for 182 weeks
Aldurazyme
0.58 mg/kg Aldurazyme every week for 208 weeks
placebo
Placebo for 26 weeks
University of Rochester, Rochester
The Childrens Hospital of Philadelphia, Philadelphia
Children's Hospital Klinikum Nord Heidberg, Hamburg
University of North Carolina at Chapel Hill, Chapel Hill
Emory University School of Medicine, Atlanta
Medizinishe Hochshule Hannover, Hanover
University of South Alabama, Mobile
Toledo Children's Hospital, Toledo
Children's Hospital at the University Hospital of Heidelberg, Heidelberg
Merle West Medical Center, Klamath Falls
Rhode Island Hospital, Providence
Hospital Universatario de Universidade Federal de Santa Catarina, Florianópolis
Hospital Infantil Joana de Gusmao, Florianópolis
The Hospital for Sick Children, Toronto
Alberta Children's Hospital, Calgary
Children's Hospital Klinikum der F.S. Universitat, Jena
Catholic University Sacro Cuore, Rome
Academisch Ziekenhuis Rotterdam, Rotterdam
Blackpool Victoria Hospital, Blackpool
Belfast City Hospital, Belfast
Birmingham Children's Hospital, Birmingham
Bristol Royal Hospital for Children and Frenchay Hospital, Bristol
Gartnavel Hospital, Glasgow
Great Ormond Street Hospital for Sick Children and NHS Trust, London
Royal Victoria Hospital, Newcastle upon Tyne
BioMarin/Genzyme LLC
INDUSTRY
Genzyme, a Sanofi Company
INDUSTRY